Catheter Ablation for Atrial Fibrillation in Structural Heart Disease: A Review.
Francesco Maria Angelo BrascaRoberto MenèGiovanni Battista PeregoPublished in: Journal of clinical medicine (2023)
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Patients with structural heart disease (SHD) are at an increased risk of developing this arrhythmia and are particularly susceptible to the deleterious hemodynamic effects it carries. In the last two decades, catheter ablation (CA) has emerged as a valuable strategy for rhythm control and is currently part of the standard care for symptomatic relief in patients with AF. Growing evidence suggests that CA of AF may have potential benefits that extend beyond symptoms. In this review, we summarize the current knowledge of this intervention on SHD patients.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- end stage renal disease
- clinical practice
- healthcare
- heart failure
- pulmonary hypertension
- newly diagnosed
- randomized controlled trial
- percutaneous coronary intervention
- ejection fraction
- peritoneal dialysis
- prognostic factors
- protein kinase
- blood pressure
- physical activity
- pain management
- patient reported outcomes
- acute coronary syndrome
- venous thromboembolism
- mitral valve